Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00911729
NCT00911729TerminatedNot Applicable

Content Validation of the EORTC QLQ-C30 Version 3.0, and NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma

Molecular Insight Pharmaceuticals, Inc.1 site in 1 country24 target enrollmentStarted: April 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
24
Locations
1
Primary Endpoint
The main objective of this study is to evaluate content validity of the NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma and EORTC-QLQ-C30 in patients with pheochromocytoma or paraganglioma.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Provide written informed consent and be willing to comply with protocol requirements
  • •Participant is aged ≥ 18
  • •Have a documented (medical record) diagnosis of either pheochromocytoma or paraganglioma with active symptoms or within 60 days of curative therapy

Exclusion Criteria

  • •Patient is currently asymptomatic from pheochromocytoma/paraganglioma diagnosis or duration > 60 days from curative therapy
  • •Participant has a clinically significant disorder, including alcohol or drug abuse, which may interfere with study participation or which may affect the outcome of the study as judged by the investigator.
  • •Participant has a mental disability or significant mental illness, legal incapacity or limited legal capacity or any other lack of fitness, in the investigator's opinion, to preclude the subject's participation in or ability to complete the study.
  • •Participant is currently too unwell to take part in the study.

Outcomes

Primary Outcomes

The main objective of this study is to evaluate content validity of the NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma and EORTC-QLQ-C30 in patients with pheochromocytoma or paraganglioma.

Time Frame: Single Visit

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Investigating the Equivalence of the EORTC QLQ-C30 and the QLQ-F17Quality of LifeCancer
NCT05479682University Hospital Regensburg2,672
Not yet recruiting
Not Applicable
Development of a Quality of Life Questionnaire suitable for adolescent cancer patients.
CTRI/2021/04/032851niversity of Southampton
Completed
Not Applicable
A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without StomaRectal Cancer
NCT01181557Fondazione IRCCS Istituto Nazionale dei Tumori, Milano236
Completed
Not Applicable
ClinRO Sedation ValidationPediatric Sedation
NCT03956342Duke University35
Unknown
Not Applicable
European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module UpdateQuality of Life
NCT02979678Medical University of Graz260